In vitro and preclinical in vivo experiments in arthritis have uncovered weight-loss-independent anti-inflammatory and chondroprotective properties of GLP-1RAs
Anti-Inflammatory Benefits of Semaglutide: State of the Art. Journal of Clinical & Translational Endocrinology , vol
GLP-1RA Lipid-Specific Outcomes While the GLP-1RAs used for weight loss, semaglutide and tirzepatide, have garnered much focus, multiple other GLP-1RA medications have shown positive outcomes on lipid profiles: dulaglutide has shown reduction in total cholesterol and LDL-C [65], liraglutide has shown reduction in LDL-C and ApoCIII [66], and exenatide has shown reduction in LDL-C and total cholesterol and increase in HDL-C [67]
A recent systemic review and meta-analysis published in the British Medical Journal (BMJ) found that while people tend to lose more weight more quickly with GLP-1s compared to traditional behavioral weight loss programs like exercise and diets, they may gain weight back faster after they stop taking the drugs compared to after they stop these lifestyle changes
For cold-chain deliveries, a signature is required to ensure someone is available to receive the medication promptly and maintain product integrity
Astrocytic Regulation: Emerging evidence suggests GLP-1 signaling in astrocytes regulates fatty acid oxidation and mitochondrial integrity, which is crucial for maintaining central energy balance (Zheng et al., 2024)
